EUVIMEDEUVIMED entdecken
Open Access

Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database

Timothy E Ritter, Christina J Hanson, Christopher Fernandes, Joanna P MacEwan, Xin Zhao, Craig S Parzynski iD, Daniel Mercer, Erik Ness, Darren Wheeler, Kris V Kowdley iD, Tracy Mayne iD

Journal of Comparative Effectiveness Research · 2025

DOI: 10.57264/cer-2024-0198 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Comparative Effectiveness Research, 2025. Verfasst von Timothy E Ritter und 10 weiteren Autor:innen. Beteiligte Einrichtung: GI Alliance Research, 620 E Southlake Blvd, Southlake, TX 76092, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Biliary. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To assess the predictive effect of threshold deviations for multiple liver biomarkers on negative clinical outcomes, including hepatic decompensation, liver transplantation, and death in patients with primary biliary cholangitis (PBC) using longitudinal data from a large administrative claims database. Materials & methods: A time-dependent Cox proportional hazards model with time-dependent covariates assessed time to first occurrence of hospitalization for hepatic decompensation, liver transplantation, or death in patients with PBC in the Optum Clinformatics Data Mart™ database. Separate models analyzed proportion of time outside prespecified biomarker thresholds (defined as multiples of upper limit of normal [ULN] for alkaline phosphatase [ALP], total bilirubin [TB], aspartate aminotransferase [AST], and alanine aminotransferase [ALT]; lower limit of normal for albumin). Another model evaluated both ALP and TB with the lowest relevant threshold applied for each biomarker.

Results

Overall, 2402 patients were included; 85.3% were female, mean age was 63.3 years, median follow-up was 2.2 years (interquartile range: 1.1–3.9 years). On average, patients had approximately five reported measurements for each biomarker evaluated. Each 10% increase in time outside thresholds was associated with a 6.5%, 9.2%, 9.9%, 7.3% and 23.3% increase in risk of negative outcomes for ALP, TB, AST, ALT and albumin, respectively.

Conclusion

In patients with PBC, values outside predefined thresholds for biomarkers including ALP, TB, AST, ALT and albumin strongly predicted negative clinical outcomes. These findings highlight the importance of managing biomarkers beyond ALP in monitoring and the treatment of patients with PBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Cirrhosis, BiliaryHumansFemaleMaleBiomarkersMiddle AgedAlkaline PhosphataseAlanine TransaminaseAspartate AminotransferasesAgedLiver TransplantationBilirubinDatabases, FactualProportional Hazards ModelsLongitudinal Studies

Stichwörter der Autor:innen

biochemical markersclinical outcomesprimary biliary cholangitisreal-world datatreatment guidelines

Substanzen

BiomarkersAlkaline PhosphataseAlanine TransaminaseAspartate AminotransferasesBilirubin

Autor:innen und Institutionen

  • GI Alliance Research, 620 E Southlake Blvd, Southlake, TX 76092, USA.
  • South Denver Gastroenterology, 499 E Hampden Ave #420, Englewood, CO 80113, USA.
  • Stanford Medicine, Emergency Medicine, 900 Welch Road, Suite 350, Palo Alto, CA 94304, USA.
  • Genesis Research Group, 111 River St Ste 1120, Hoboken, NJ 07030, USA.
  • Intercept Pharmaceuticals, 305 Madison Ave, Morristown, NJ 07960, USA.
  • Liver Institute Northwest & Elson S. Floyd College of Medicine, Washington State University, 3216 NE 45th Place #212, Seattle, WA 98105, USA.

ORCID-Profile: Craig S Parzynski, Kris V Kowdley, Tracy Mayne

Zitieren

APA

Ritter, T. E., Hanson, C. J., Fernandes, C., MacEwan, J. P., Zhao, X., Parzynski, C. S., Mercer, D., Ness, E., Wheeler, D., Kowdley, K. V., & Mayne, T. (2025). Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database. Journal of Comparative Effectiveness Research. https://doi.org/10.57264/cer-2024-0198

Vancouver

Ritter TE, Hanson CJ, Fernandes C, MacEwan JP, Zhao X, Parzynski CS, et al. Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database. Journal of Comparative Effectiveness Research. 2025. doi:10.57264/cer-2024-0198

BibTeX
@article{Ritter2025,
  author = {Ritter, Timothy E and Hanson, Christina J and Fernandes, Christopher and MacEwan, Joanna P and Zhao, Xin and Parzynski, Craig S and Mercer, Daniel and Ness, Erik and Wheeler, Darren and Kowdley, Kris V and Mayne, Tracy},
  title = {Association of liver biomarker values beyond current thresholds and negative clinical outcomes in primary biliary cholangitis: analysis of a real-world healthcare claims database},
  journal = {Journal of Comparative Effectiveness Research},
  year = {2025},
  doi = {10.57264/cer-2024-0198}
}
Kostenlos starten →